The interactive peptide guide
Peptides, explained
Tiny chains of amino acids are reshaping recovery, longevity, and metabolic medicine. Here is the honest, interactive breakdown — the science, the history, the real results, and the risks nobody puts on the label.
Start here
So… what is a peptide?
A peptide is a short chain of amino acids — the same building blocks that make up proteins, just far smaller. Where a protein can be thousands of units long, a peptide is usually 2 to 50. That small size is the whole point: peptides act like precise biological messages, telling cells to repair, signal, or switch genes on.
A peptide chain — tap an amino acid
Signals, not sledgehammers
Most peptides nudge a pathway your body already uses, rather than overriding it.
Naturally occurring
Many therapeutic peptides are fragments of proteins your body already makes.
Highly specific
Their shape fits a target like a key, so effects can be targeted and dose-sensitive.
The two families
Two ways peptides work
Almost every peptide falls into one of two camps. Toggle between them.
Metabolic & growth peptides
These bind a specific, well-mapped receptor and trigger a predictable cascade. The biology is clearer and the clinical data is deeper. Think GLP-1 agonists (semaglutide, tirzepatide), growth-hormone secretagogues, and the new triple-agonist retatrutide.
Where they came from
A surprisingly long history
Peptide medicine isn't new — it's been quietly developing for over a century.
1900s
Pavlov's gastric juice
Ivan Pavlov's work on dog gastric secretions seeds the idea that the gut produces protective compounds — the distant origin of BPC-157.
1970s
Soviet bioregulators
Dr. Vladimir Khavinson develops small peptides to fight the rapid aging seen in submariners and cosmonauts — the start of Epithalon and Pinealon.
1991
BPC-157 isolated
A Croatian research group isolates a 15-amino-acid fragment of a protective gastric protein and names it Body Protection Compound.
2000s
Thymic & copper peptides
Thymosin Alpha-1 reaches the clinic as an immune drug; GHK-Cu becomes a skincare staple for collagen remodeling.
2017
The GLP-1 era begins
Semaglutide and later tirzepatide redefine metabolic medicine, lowering body-fat set points by 10–30%.
2026
Triple agonists & the boom
Retatrutide (GLP-1 + GIP + glucagon) leads a wave of next-gen compounds as peptide interest goes mainstream.
Under the hood
How they actually work
Three core mechanisms cover most of the field.
Receptor agonism
The peptide fits a cell-surface receptor and switches on a cascade — like GLP-1 telling the body it's full and insulin-sensitive.
Growth & repair signaling
Peptides like BPC-157 raise VEGF and encourage blood-vessel formation and cell migration, accelerating tissue healing.
Epigenetic switching
Bioregulators like Epithalon bind grooves in DNA to expose promoter regions, restarting more youthful gene-transcription programs.
The lineup
Meet the major peptides
Tap any peptide to see how it works, what people use it for, and what to watch out for.
How it works
A 15-amino-acid fragment that boosts VEGF signaling, blood-vessel formation, and cell migration — and can counteract the healing-suppression of corticosteroids. It also modulates the gut-brain axis.
Reported results
Anecdotal faster soft-tissue and tendon recovery; some report blunted effects of stimulants like alcohol or amphetamines.
Side effects & risks
Triggers angiogenesis, so a theoretical concern is feeding pre-existing tumors. Some users report transient anhedonia or blunted stimulants.
Status: Reclassified by the FDA from Category 1 to Category 2 for compounding.
Why the noise
Why the hype exploded
Two forces collided: GLP-1 drugs produced visible, undeniable body transformations, and a wave of executives and celebrities openly combined them with growth-hormone secretagogues and testosterone — the so-called "trinity stack." Add a podcast-driven longevity culture and a frictionless gray market, and peptides went from niche biohacking to dinner-table conversation.
10–30%
body-fat set point drop from GLP-1s
3
compounds in the celebrity "trinity stack"
~100%
of raw peptide API sourced from China
1991
the year BPC-157 was first isolated
Measure, don't guess
The tests that actually matter
Before and during any protocol, these are the markers clinicians track. Tap to expand.
The honest part
Risks & what nobody labels
The sourcing illusion
Virtually 100% of active peptide raw material comes from China. "Made in America" usually means only final mixing or packaging happened domestically.
Gray & black markets
"For research purposes only" vials carry real batch-to-batch contamination and mislabeling risk — people have injected tanning peptides thinking they bought a GLP-1.
Regulatory fluidity
The FDA moved BPC-157 from Category 1 to Category 2 for compounding; pharmacies tweak chemical salts (acetate → arginate) to navigate restrictions.
Theoretical cancer risk
Angiogenic peptides could feed pre-existing tumors. Screening and physician oversight aren't optional.
Do this first
Peptides can't outrun bad foundations
Both experts are blunt: advanced protocols are useless without the basics locked in.
Circadian alignment
Consistent sleep and wake times anchor every other system.
Morning sunlight
Clean light exposure sets hormones and mood for the day.
Deep, unfragmented sleep
Repair happens at night — no peptide replaces it.
Low-processed nutrition
A whole-food base is the platform everything else stands on.
Quick answers
Frequently asked
- It depends on the specific peptide and your country. Some (like thymosin alpha-1 or GLP-1 drugs) are approved medicines; many others are sold only "for research purposes" and exist in a legal gray area. Always check local regulations and work with a clinician.
Tracking a protocol? Don't do it in a notes app.
TrackPep logs doses, rotates injection sites, watches side-effect patterns, and shows your trends — built specifically for peptides and GLP-1s.
Start freeThis page is educational only and is not medical advice. Peptides carry real risks and many are not approved medicines. Always consult a qualified clinician before starting any protocol.